Search Result "Fibric acid derivatives"
Pleiotropic Effects of Fenofibrate
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 5 Year: 2009 Page: 517-528
Author(s): V. Tsimihodimos, E. Liberopoulos, M. Elisaf
Fenofibrate: Metabolic and Pleiotropic Effects
Journal: Current Vascular Pharmacology
Volume: 3 Issue: 1 Year: 2005 Page: 87-98
Author(s): Vasilis Tsimihodimos, George Miltiadous, Stella S. Daskalopoulou, Dimitri P. Mikhailidis, Moses S. Elisaf
Design and Synthesis of Novel 1,3-Dioxane-2-carboxylic Acid Derivatives as PPARα/γ Dual Agonists
Journal: Letters in Drug Design & Discovery
Volume: 7 Issue: 6 Year: 2010 Page: 421-429
Author(s): Harikishore Pingali, Mukul Jain, Shailesh Shah, Pankaj Makadia, Pandurang Zaware, Jeevankumar Jamili, Kalapatapu V.V.M. Sairam, Pravin Patil, Dinesh Suthar, Suresh Giri, Harilal Patel, Pankaj Patel
Renal Cytochrome P450-Derived Eicosanoids and Hypertension
Journal: Current Hypertension Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 227-236
Author(s): Mong-Heng Wang
Fungal Mediated Generation of Mammalian Metabolites of Fenofibrate and Enhanced Pharmacological Activity of the Main Metabolite Fenofibric Acid
Journal: Drug Metabolism Letters
Volume: 8 Issue: 2 Year: 2014 Page: 88-95
Author(s): G. Shyam Prasad,P. Govardhan,S. Girisham,S.M. Reddy
Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 6 Year: 2008 Page: 574-587
Author(s): M. S. Elisaf, M. Florentin, E. N. Liberopoulos, D. P. Mikhailidis
The Role of High-Density Lipoprotein Cholesterol in the Prevention and Possible Treatment of Cardiovascular Diseases
Journal: Current Molecular Medicine
Volume: 6 Issue: 5 Year: 2006 Page: 571-587
Author(s): B. G. Choi, G. Vilahur, D. Yadegar, J. F. Viles-Gonzalez, J. J. Badimon
Fenofibrate and Metabolic Syndrome
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 138-148
Author(s): Aldi T. Kraja, Michael A. Province, Robert J. Straka, Jose M. Ordovas, Ingrid B. Borecki, Donna K. Arnett
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 33-39
Author(s): Mollie A. Jay, Jun Ren
Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 3 Year: 2005 Page: 4161-4175
Author(s): S. S. Daskalopoulou, V. Tzovaras, D. P. Mikhailidis, M. Elisaf